Capillary microscopy is a useful tool with which to recognize the failure of the epidermis to induce a normal dermis. For instance a distorted inadequate vasculature-telangiectasia has been observed in many states predisposing to carcinoma, i.e. ataxia telangiectasia, epidermolysis bullosa, lichen sclerosus et atrophicus and poikiloderma, and such tissues are commonly atrophic. Some such as ataxia telangiectasia are known to be defects of induction of mesenchyme. There is evidence for an epidermal angiogenic factor acting by inducing a scaffold of fibrin or reticulin (Nishioka & Ryan 1972 , Wolf & Harrison 1973 . Deficiency of such a factor was postulated as a cause of the atrophy of ageing skin (Ryan 1966a (Ryan , 1973 . Fortunately atrophic skin is also lazy, otherwise neoplasia might be seen more commonly. It is only when a tissue such as lichen sclerosus et atrophicus is injured that it is stimulated to take advantage of the inadequate dermis and invade.
While agreeing and admiring the concepts developed by Pinkus (1970) which concern stroma it will be seen that I am not convinced that the aim of the epidermis is habitually outwards. The appearance of any skin lesion depends on its underlying tissue abnormalities. It would help in management of patients to be able to pin point abnormalities in tissue dynamics from physical signs. Jf it is not possible to decide where the fault lies from clinical examination then it seems reasonable to use laboratory tests to supplement visual data. The term 'epidermal cell kinetics' has come to mean the rate of epidermal cell proliferation, although it should include epidermal cell movement. 1 wish to discuss how alterations in epidermal cell proliferation may influence clinical findings.
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Techniques
Most of the data have been collected by two techniques. The first employs tritiated thymidine which is specifically incorporated into nuclear DNA during the premitotic synthetic phase of the generative cycle. Cells with nuclei that contain the thymidine are detectable autoradiographically as 'labelled cells'. The labelling index denotes the proportion of such labelled basal and suprabasal cells in the basal layer and indicates the rate of epidermal cell proliferation. In most laboratories, it stands at approximately 5 % for normal adult epidermis. The other technique is an in vitro test which measures uptake of tritiated precursor compounds by thin sheets of skin removed with a Castroviejo Keratotome. Tritiated thymidine is used in the indfibation medium to give an index of the rate of DNA synthesis and tritiated proline and histidine to give information conceining rate of protein synthesis by the epidermis (Marks, Halprin, Fukui & Graff 1971 . The results are obtained as corrected counts per minute, per square millimetre of epidermis per hour for each of the precursors and expressed in 'thymidine units', 'proline units' and 'histidine units'.
Results anzd Discussion
In psoriasis there is a striking increase in the rate of epidermal cell proliferation (Van Scott & Ekel 1963 , Weinstein & Frost 1969 . Weinstein & Frost found that in psoriasis an average 22.7 % of the germinative compartment of the epidermis became labelled. In normal epidermis it takes approximately 28 days for a cell to travel from the basal layer to the surface, in psoriasis about 4 days. Both observations imply a 6 or 7 times Table 1 Results of incorporation of tritiated precursor compounds in epidermis of normal subjects and in epidermis of subjects with psoriasis and pityriasis rubra pilaris (means and s.e. means) 7.3 ± 2.8 2.4 i 1.5 rubra pilaris increase in rate of epidermal cell production. However, all these investigations have shown wide variation in values for individual lesions of psoriasis.
The in vitro method confirms the increase in the rate of DNA synthesis in psoriasis (Table 1) ; the 'average' increase is less than might be expected and this could be due to a number of reasons which it is inappropriate to discuss here.
We have found that accelerated epidermopoiesis is by no means specific to psoriasis; for example, we found a similar increased rate of DNA and protein synthesis in non-bullous ichthyosiform erythroderma (Table 2 ) and in pityriasis rubra pilaris (Table 1) . Two other red and scaling rashes have been investigated using autoradiographic methods. In lichenified eczema the labelling index was 25.9% (Marks & Wells 1973) and in seborrhoeic dermatitis affecting the scalp 23.5% . Thus, all conditions discussed so far which are red and scaly (psoriasiform) have a high rate of epidermal cell proliferation. Regrettably this appears to be an, oversimplification. There are some red and scaly conditions characterized by parakeratosis histologically which only show a moderate increase in the rate of epidermopoiesis. Pityriasis lichenoides, for example, has an epidermal cell labelling index of 15.2 % and epidermal cell death figures strongly as part of the tissue changes (Marks & Black 1972 ). In addition some scaling conditions are not associated with a high rate of cell production, for example, lamellar and dominant types of ichthyosis (Tables 2 and 3) . Where there is clinical atrophy there does appear to be a low rate of epidermal cell proliferation (or at least of DNA Table 2 Results of incorporation of tritiated precursors in 4 patients with two rare types of ichthyosis (Table 3) . It is possible for a normal appearing skin to show abnormalities in epidermal cell proliferation. For example, the normal looking skin of psoriatics shows an increased rate of epidermopoiesis (Table 1 ). In addition, in Cardiff, we recently studied the rate of epidermal cell production in thyroid disease (Holt et al. 1974 ). There certainly seems to be increased epidermal activity in thyrotoxicosis without much to be seen clinically for it. In myxoedema there is a decrease in the labelling index to 4.0±0.7%, while the labelling index for thyrotoxicosis is 8.3±0.5%. Inflammatory conditions that primarily involve the dermis may also show a secondary considerable increase in the rate of epidermal cell production without appreciable clinical change e.g. rosacea (Marks 1973) . In this paper I have discussed whether there is a relationship between clinical morphology and epidermal cell kinetics. We have seen that psoriasiform conditions are associated with a 'high output' but that this is not invariably so. We have shown that there may be changes in epidermal cell output in normal appearing skin. Clinical atrophy is accompanied by decreased cell production but the converse certainly is not true and a high output is not necessarily associated with any clinical abnormality. While there is a relationship between epidermal cell kinetics and the clinical appearance this is neither clear-cut nor consistent.
